Survanta 25 mg/mL (Beractant SUSPENSION) 25 mg/mL

Survanta 25 mg/mL is a suspension used for respiratory support in premature infants. This single-use suspension, manufactured by AbbVie Inc., is administered endotracheally to aid lung function.

Strength

25 mg/mL

Pack Size

1 VIAL, SINGLE-USE in 1 CARTON (0074-1040-08) / 8 mL in 1 VIAL, SINGLE-USE

Manufacturer / TM Owner

AbbVie Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Survanta 25 mg/mL is primarily used to treat or prevent respiratory distress syndrome (RDS) in premature infants. This condition often occurs due to a lack of surfactant in the lungs, which is crucial for proper breathing. Survanta helps to improve lung function and reduce the need for oxygen therapy. It is administered endotracheally, directly into the airway, to provide immediate support.

Side Effects

Common effects of Survanta 25 mg/mL may include temporary changes in breathing patterns immediately following administration. Some infants may experience mild respiratory discomfort or require additional ventilation support. These effects are typically monitored and managed by healthcare professionals.

Precautions & Warnings

Survanta 25 mg/mL should be handled with care, ensuring proper storage and administration techniques. It is a single-use suspension, and any unused portion should be discarded. Healthcare providers should follow strict hygiene protocols to prevent contamination. Always consult a healthcare professional for specific handling instructions.

Avoid Interactions

Survanta 25 mg/mL may interact with other medications administered endotracheally. It is important to inform healthcare providers about all medications the infant is receiving. Additionally, certain medical conditions may affect the use of Survant. Always consult a healthcare professional for personalized advice.

Frequently Asked Questions

Survanta 25 mg/mL is used to treat or prevent respiratory distress syndrome in premature infants by providing surfactant support.

Survanta 25 mg/mL is administered endotracheally, directly into the airway, by healthcare professionals.

Common effects may include temporary changes in breathing patterns and mild respiratory discomfort immediately after administration.

Yes, Survanta 25 mg/mL is a single-use suspension, and any unused portion should be discarded.

Survanta 25 mg/mL is manufactured by AbbVie Inc.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.